Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-01-04
2009-12-29
Goldberg, Jeanine A (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024300, C536S023200, C435S006120, C435S091100, C435S091200, C435S325000, C435S320100
Reexamination Certificate
active
07638614
ABSTRACT:
An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression, and uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.
REFERENCES:
patent: 4997757 (1991-03-01), Schiestl
patent: 5429948 (1995-07-01), Crespi et al.
patent: 5849998 (1998-12-01), Gottesman
patent: 6432639 (2002-08-01), Lichter
patent: 2002/0138855 (2002-09-01), Zhang et al.
patent: 2002/0150915 (2002-10-01), Berkenstam
patent: 2003/0145341 (2003-07-01), Zhang
patent: 644267 (1995-03-01), None
patent: 1 206 906 (2002-05-01), None
patent: WO 99/13106 (1999-03-01), None
patent: WO 99/35246 (1999-07-01), None
patent: WO 99/48915 (1999-09-01), None
patent: WO 99/61622 (1999-12-01), None
patent: WO 01/11951 (2001-02-01), None
patent: WO 01/20025 (2001-03-01), None
patent: WO 01/20026 (2001-03-01), None
patent: WO 01/79845 (2001-10-01), None
patent: WO 02/08451 (2002-01-01), None
patent: WO 02/25270 (2002-03-01), None
patent: WO 02/36784 (2002-05-01), None
patent: WO 02/083897 (2002-10-01), None
patent: WO 02/088305 (2002-11-01), None
Eur. J. Biochem. vol. 218, pp. 585-595, 1993.
Pietrzkowski et al. (Experimental Cell Research, 193, 283-290 (1991)).
Chan et al. (Plant Molecular Biology 46 :131-141, (2001)).
Omilli et al. (Molecular and Cellular Biology, Jun. 1986, p. 1875-1885).
Hashimoto et al.,Eur. J. Biochem218:585-595 (1993).
Dogra et al.,Clinical and Experimental Pharmacology and Physiology, 25:1-9 (Jan. 1998).
Kolars et al.,Pharmacogenetics, 4:247-259 (1994).
Kovaleva et al.,Biochem, Biophys. Res. Comm., 221:129-132 (1996).
Ogg et al.,Eur. J. of Drug Metabolism and Pharmacokinetics, 22(4):331-313 (1997).
Hakkela et al.,Crit. Rev. Toxicol. 28(1):35-72 (Jan. 1998).
Gonzalez et al.,Mol. Cell Biol., 10:1470-1475 (1990):DNA, 7:79-86 (1988); andGenbank Accession No. D1131.
J.M. Lehmann et al., “The Human Orphan Nuclear Receptor PXR is Activated by Compounds that Regulate CYP3A4 Gene Expression and Cause Drug Interactions,”J. Clin. Invest., 102(5)1016-1023 (1998).
G. Betilsson et al., “Identification of a Human Nuclear Receptor Defines a New Signaling Pathway for CYP3A Gene Expression and Cause Drug Interactions,”Proc. Nat'l Acad. Sci., USA, 95:12208-12213 (Oct. 1998).
Blumberg et al., “SXR, A Novel Steroid and Xenobiotic Sensing Nuclear Receptor,”Genes&Dev., 12:3195-3205 (1998).
D.J. Mangelsdorf et al., “The Nuclear Receptor Superfamily: The Second Decade,”Cell, 83:835-839 (Dec. 1995).
M. Baes et al., “A New Orphan Member of the Nuclear Hormone Receptor Superfamily that Interacts with a Subset of Retinoic Acid Response Elements,”Mol. Cell Biol., 14:1544-1552—(Mar. 1994).
T.R. Rebbeck et al., “Modification of the Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4,”J. Nat'l Cancer Inst., 90(16):1225-1229 (Aug. 1998).
C.A. Felix et al., “Association of CYP3A4 Genotype with Treatment-Related Leukemia,”Proc. Nat'l Acad. Sci. USA, 95:13176-13181 (Oct. 1998).
Goodwin et al.,Mol. Pharmacol., 56:1329-1339 (1999).
Bertilsson, et al.,Functionally Conserved Xenobiotic Responsive Enhancer in Cytochrome P 450 3A7, Biochemical and Biophysical Research Communications 280, 139-144 (2001).
Barwick et al. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.Molecular Pharmacology. (1996) 50(1):10-6.
Lawn et al. The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA.Cell(1978) 15: 1157-1174.
Zilliacus et al. Modulation of DNA-binding specificity within the nuclear receptor family by substitutions at a single amino acid position.Proteins. (1995) 21(1):57-67.
Fougerousse et al. Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes.Human Molecular Genetics(2000) 9(4):659.
Valerio et al. Activity of the adenosine deaminase promoter in transgenic mice.Nucleic Acids Research(1988) 16:10083-10097.
Ramsden et al. Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice.Journal of Biological Chemistry(1993) 268(29):21722-6.
Jones et al. Induction of the Cyp1a-1 dioxin-responsive enhancer in transgenic mice.Nucleic Acids Research(1991) 19(23):6547-51.
Campbell et al. Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation.Journal of Cell Science(1996) 109(11):2619-25.
Komori et al. Transgenic Drosophila carrying mammalian cytochrome P-4501A1: an application to toxicology testing.Carcinogenesis(1993) 14(8):1683-8.
Kliewer et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.Cell(1998) 92(1):73-82.
Wolf et al. Use of transgenic animals in understanding molecular mechanisms of toxicity.Journal of Pharmacy and Pharmacology. (1998) 50(6):567-74.
Ogg et al. A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro. Xenobiotica. 1999 29(3):269-79.
Kamataki T, Yokoi T, Fujita K, Ando Y. “Preclinical approach for identifying drug interactions.” Cancer Chemother Pharmacol 42 Suppl: S50-3 (1998).
Olsen A K, Hansen K T, Friis C. “Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alpha-ethynylestradiol.” Chem Biol Interact 107(1-2):93-108 (1997).
Achira M et al, “Comparative studies to determine the selective inhibitors for p-glycoprotein and cytochrome P4503A4.” AAPS Pharmsci [Electronic Resource]. 199, 1(4): E18.1-E18.6 (1999).
Ahern H. “Biochemical, reagent kits offer scientists good return on investment.” The Scientist 9(15):20 (Jul. 1995).
Goodwin B et al. Genbank Accession No. AF185589, Dec. 1999.
Martin D I K and Whitelaw E. The vagaries of variegating transgenes.Bioessays18:919-923 (1996).
Robertson, G et al. Position-dependent variegation of globin transgene expression in mice.Proc. Natl. Acad. Sci. USA 92:5371-5375 (1995).
Robertson, G et al. Age dependent silencing of globin transgenes in the mouse.Nucleic Acids Research24:1465-1471 (1996).
Dobie K W et al. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus.Proc. Natl. Acad. Sci. USA 93:6659-6664 (1996).
Elliot J et al. Random activation of a transgene under control of a hybrid hCD2 locus control region/Ig enhancer regulatory element.EMBO J. 14:575-584 (1995).
Henikoff S Conspiracy of silence amongst repeated transgenes.Bioessays20:532-535 (1998).
Garrick D et al. Repeat-induced gene silencing in mammals.Nature Genetics18:56-59 (1998).
Jones S A et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.Mol. Endocrinol. 14:27-39 (2000).
Wei et al. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.Nature407(6806):920-923 (2000).
Xie W et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR.Nature406(6794):435-9 (2000).
Smith, T.F. and Waterman M.S. “Comparison of biosequences” (1981)Ad. Appl. Math., 2:482-489.
Needleman, S.B. and Wunsch, C.D. “A general method applicable to the search for similarities in the amino acid sequence of two proteins.” (1970)J. Mol. Biol. 48(3):443-453.
Gellner K et al: “Genomic Organization Of The Human Cyp3a Locus: Identification Of A New, Inducible Cyp3a Gene”Pharmacogenetics,11(2):111-121 (Mar. 2001).
Toide K et al: “Gene structure of mouse Cyp3all: Evidence for an enhancer element within its 5′ flanking sequences”Archives Of Biochemistry And Biophysics, 338(1): 43-49 (1997).
Itoh S et al: “Isolation of a promoter region in mouse cytochrome P450
Goodwin Bryan James
Liddle Christopher
Goldberg Jeanine A
Husch Blackwell Sanders Welsh & Katz
The University of Sydney
LandOfFree
Xenobiotic related induction of gene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xenobiotic related induction of gene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xenobiotic related induction of gene expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4110822